{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:48:38Z","timestamp":1775879318611,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1253\/circj.cj-08-0593","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T00:56:58Z","timestamp":1232672218000},"page":"352-355","source":"Crossref","is-referenced-by-count":14,"title":["Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology (TRUTH Study)"],"prefix":"10.1253","volume":"73","author":[{"given":"Tsuyoshi","family":"Nozue","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tsurumi Nishiguchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Tohyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanagawa Cardiovascular and Respiratory Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiratsuka Kyosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kunishima","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Yokosuka Kyosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ebina General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichi","family":"Takeyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Showa University Fujigaoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tokai University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Women's Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sozu","sequence":"additional","affiliation":[{"name":"The Center for Advanced Medical Engineering and Informatics, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Michishita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Kanagawa PTCA Conference Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.","DOI":"10.1056\/NEJM199511163332001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, et al. Reduction in cardiovascular events during pravastatin therapy: Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995; 92: 2419-2425.","DOI":"10.1161\/01.CIR.92.9.2419"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.","DOI":"10.1056\/NEJM199811053391902"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-1009.","DOI":"10.1056\/NEJM199610033351401"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.","DOI":"10.1056\/NEJMoa040583"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.","DOI":"10.1056\/NEJMoa050461"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al; REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.","DOI":"10.1001\/jama.291.9.1071"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.","DOI":"10.1001\/jama.295.13.jpc60002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamada T, Azuma A, Sasaki S, Sawada T, Matsubara H; REACH Study Group. Randomized evaluation of atorvastatin in patients with coronary heart disease: A serial intravascular ultrasound study. Circ J 2007; 71: 1845-1850.","DOI":"10.1253\/circj.71.1845"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.","DOI":"10.1161\/01.CIR.0000140261.58966.A4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takayama T, Hiro T, Yamagishi M, Daida H, Saito S, Yamaguchi T, et al. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects). Circ J 2007; 71: 271-275.","DOI":"10.1253\/circj.71.271"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200-2206.","DOI":"10.1161\/01.CIR.0000035654.18341.5E"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, et al. Accuracy of in vivo coronary plaque morphology assessment: A validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006; 47: 2405-2412.","DOI":"10.1016\/j.jacc.2006.02.044"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kajinami K, Takekoshi N, Saito Y. Pitavastatin: Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 2003; 21: 199-215.","DOI":"10.1111\/j.1527-3466.2003.tb00116.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takashima H, Ozaki Y, Yasukawa T, Waseda K, Asai K, Wakita Y, et al. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque. Circ J 2007; 71: 1678-1684.","DOI":"10.1253\/circj.71.1678"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Miyauchi K, Kimura T, Morimoto T, Nakagawa Y, Yamagishi M, Ozaki Y, et al. Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): Rationale and design. Circ J 2006; 70: 1624-1628.","DOI":"10.1253\/circj.70.1624"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al; MEGA Study Group. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomized controlled trial. Lancet 2006; 368: 1155-1163.","DOI":"10.1016\/S0140-6736(06)69472-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996; 37: 45-53.","DOI":"10.1016\/S0022-2275(20)37634-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kohno H, Sueshige N, Oguri K, Izumidate H, Masunari T, Kawamura M, et al. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem 2000; 33: 243-253.","DOI":"10.1016\/S0009-9120(00)00065-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kujiraoka T, Iwasaki T, Ishihara M, Ito M, Nagano M, Kawaguchi A, et al. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. J Lipid Res 2003; 44: 2006-2014.","DOI":"10.1194\/jlr.D300021-JLR200"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/2\/73_CJ-08-0593\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:19:04Z","timestamp":1775877544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/2\/73_CJ-08-0593\/_article"}},"subtitle":["Rationale and Design"],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-08-0593","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]},"article-number":"CJ-08-0593"}}